ZEMYFeasibility Assessment of an E-Health System (ZEMY) Designed to Manage Symptoms in Patients With Breast Cancer Under Anti-Cancer Treatment

ZEMY software

Investigator's choice of anti-cancer treatment (except immunotherapy)

Percentage of Participants Who Successfully Use ZEMY

Percentage of Appropriate Automatic Messages and Recommendations for Each Symptom by ZEMY, as Evaluated by the Investigator at Each Visit

System Usability Scale Score, Rated by Participants and Healthcare Professionals (HCPs)

Satisfaction with ZEMY, Assessed on a Visual Analog Scale by Participants and HCPs

Percentage of Participant Answered Entries per ZEMY Requests for Solicited Symptom Information

Number of Automatic Messages Generated by ZEMY per Participant Over the Study Period

Number of Automatic Messages Generated by ZEMY per Symptom Over the Study Period

Number of Recommendations Generated by ZEMY per Participant Over the Study Period

Number of Recommendations Generated by ZEMY per Symptom Over the Study Period

Number and Type of Device Deficiencies

Number and Type of Adverse Device Effects

Number and Type of Serious Adverse Device Effects

Number and Type of Unanticipated Serious Adverse Device Effects

Change From Baseline in the EuroQoL 5-Dimension (EQ-5D-5L) Health Questionnaire Score at Each Study Visit

Change From Baseline in the European Organization for Research and Treatment of Cancer's Quality-of-Life Questionnaire (EORTC QLQ-30) Score at Each Study Visit

Change From Baseline in the European Organization for Research and Treatment of Cancer's Breast Cancer-Specific Quality-of-Life Questionnaire (EORTC QLQ-BR23) Score at Each Study Visit